BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2786689)

  • 21. Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.
    Griffith MJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5460-4. PubMed ID: 6577437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular-mass dependence of dextran sulfate enhancement of inactivation of thrombin and fibrinogen and on factor Xa neutralization by antithrombin III.
    Oshima G
    Biol Chem Hoppe Seyler; 1989 Jul; 370(7):715-21. PubMed ID: 2476159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of three heparin-binding serine proteinase inhibitors.
    Pratt CW; Whinna HC; Church FC
    J Biol Chem; 1992 May; 267(13):8795-801. PubMed ID: 1315739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
    Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
    Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of factor Xa with heparin does not contribute to the inhibition of factor Xa by antithrombin III-heparin.
    Owen BA; Owen WG
    Biochemistry; 1990 Oct; 29(40):9412-7. PubMed ID: 2248954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of heparin on the interaction between thrombin and hirudin.
    Stone SR; Hofsteenge J
    Eur J Biochem; 1987 Dec; 169(2):373-6. PubMed ID: 3691497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.
    Holmer E; Kurachi K; Söderström G
    Biochem J; 1981 Feb; 193(2):395-400. PubMed ID: 6914196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of heparin, NaCl and CaCl2 on the rate of the thrombin-antithrombin III reaction.
    Machovich R; Regoeczi E; Hatton MW
    Thromb Res; 1979; 15(5-6):821-34. PubMed ID: 494181
    [No Abstract]   [Full Text] [Related]  

  • 29. Kinetics of inhibitors and the mechanisms of action of antithrombin III.
    Rosenberg RD; Oosta GM
    Prog Clin Biol Res; 1981; 72():179-203. PubMed ID: 7335648
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombin-inhibitory activity of whale heparin oligosaccharides.
    Ototani N; Kodama C; Kikuchi M; Yosizawa Z
    J Biochem; 1984 Dec; 96(6):1695-703. PubMed ID: 6530392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor X.
    Jackson CM
    Prog Hemost Thromb; 1984; 7():55-109. PubMed ID: 6397768
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative effects of heparin and LMW heparin on hemostasis.
    Hirsh J; Buchanan MR
    Thromb Res Suppl; 1991; 14():11-7. PubMed ID: 1658966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular weight of heparin versus biologic activity. Some additional considerations.
    Losito R; Losito C
    Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
    [No Abstract]   [Full Text] [Related]  

  • 35. [From heparin to synthetic antithrombotic oligosaccharides].
    Petitou M
    Bull Acad Natl Med; 2003; 187(1):47-56; discussion 56-7. PubMed ID: 14556453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of heparin on thrombin inactivation by antithrombin-III.
    Machovich R; Arányi P
    Biochem J; 1978 Sep; 173(3):869-75. PubMed ID: 708377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin generation and inactivation in the presence of antithrombin III and heparin.
    Lindhout T; Baruch D; Schoen P; Franssen J; Hemker HC
    Biochemistry; 1986 Oct; 25(20):5962-9. PubMed ID: 3790498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin and protease inhibition. I. Heparin complexes with thrombin, plasmin, and trypsin.
    Smith GF; Sundboom JL
    Thromb Res; 1981 Apr 1-15; 22(1-2):103-14. PubMed ID: 6457413
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
    Scully MF; Kakkar VV
    Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.